International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

作者: Nancy U Lin , Christoph Thomssen , Fatima Cardoso , David Cameron , Tanja Cufer

DOI: 10.1016/J.BREAST.2013.03.006

关键词:

摘要: In clinical practice, the surveillance and follow-up of patients with breast cancer (BC) is quite variable. At 7th European Breast Cancer Conference, ESO-MBC Task Force convened a series lectures, followed by open debate, on use physical examination, imaging, laboratory tests in early-stage BC, for restaging evaluations among MBC. Based available data, recommends against intensive, routine radiologic or blood-based (with exception mammography) BC. As systemic therapies MBC continue to improve, this question might be re-visited context carefully controlled trial specific BC subtypes. For MBC, response therapy should generally assessed 2-3 months after initiation treatment, thereafter every 2-4 endocrine cycles chemotherapy, depending dynamics disease, location extent metastatic involvement, type treatment. Additional testing performed irrespective planned intervals if progression disease suspected (e.g. case symptoms). Use tumor markers not recommended patients, but may helpful monitoring disease. However, change alone used decision-making. Moving forward, enhanced efforts document quality life over time made order more fully evaluate risk/benefit ratio options.

参考文章(72)
R Kokko, K Holli, M Hakama, Ca 15-3 in the follow-up of localised breast cancer: a prospective study European Journal of Cancer. ,vol. 38, pp. 1189- 1193 ,(2002) , 10.1016/S0959-8049(01)00429-4
Sharon H. Giordano, Aman U. Buzdar, Terry L. Smith, Shu-Wan Kau, Ying Yang, Gabriel N. Hortobagyi, Is breast cancer survival improving Cancer. ,vol. 100, pp. 44- 52 ,(2004) , 10.1002/CNCR.11859
B E Hillner, M K McDonald, L Penberthy, C E Desch, T J Smith, P Maddux, W P Glasheen, S M Retchin, Measuring standards of care for early breast cancer in an insured population. Journal of Clinical Oncology. ,vol. 15, pp. 1401- 1408 ,(1997) , 10.1200/JCO.1997.15.4.1401
D W Chan, R A Beveridge, H Muss, H A Fritsche, G Hortobagyi, R Theriault, D Kiang, B J Kennedy, M Evelegh, Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. Journal of Clinical Oncology. ,vol. 15, pp. 2322- 2328 ,(1997) , 10.1200/JCO.1997.15.6.2322
Edward Obedian, Diana B. Fischer, Bruce G. Haffty, Second Malignancies After Treatment of Early-Stage Breast Cancer: Lumpectomy and Radiation Therapy Versus Mastectomy Journal of Clinical Oncology. ,vol. 18, pp. 2406- 2412 ,(2000) , 10.1200/JCO.2000.18.12.2406
Musa Mayer, Adrián Huñis, Ruth Oratz, Cathy Glennon, Pat Spicer, Elyse Caplan, Lesley Fallowfield, Living with metastatic breast cancer: a global patient survey Community oncology. ,vol. 7, pp. 406- 412 ,(2010) , 10.1016/S1548-5315(11)70415-6
Michele B. Drotman, Stephen C. Machnicki, Lawrence H. Schwartz, Corinne B. Winston, Hyok-Hee Yoo, David M. Panicek, Breast cancer: assessing the use of routine pelvic CT in patient evaluation. American Journal of Roentgenology. ,vol. 176, pp. 1433- 1436 ,(2001) , 10.2214/AJR.176.6.1761433